RVTY
Revvity Inc.
NYSE: RVTY · HEALTHCARE · DIAGNOSTICS & RESEARCH
$99.09
+7.36% today
Updated 2026-05-06
Market cap
$9.69B
P/E ratio
42.08
P/S ratio
3.39x
EPS (TTM)
$2.06
Dividend yield
0.32%
52W range
$81 – $118
Volume
1.1M
Revvity Inc. (RVTY) Financial statements
SEC filings — annual and quarterly data.
Profit margin
8.45%
Operating margin
20.10%
ROE
3.22%
ROA
2.22%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $1.55B | $117.15M | 40.32% | 9.80% | 7.58% |
| 2007 | $1.79B | $132.92M | 40.01% | 9.77% | 7.44% |
| 2008 | $1.96B | $128.41M | 42.61% | 10.27% | 6.55% |
| 2009 | $1.55B | $85.60M | 45.07% | 9.03% | 5.52% |
| 2010 | $1.70B | $383.92M | 43.44% | 10.14% | 22.53% |
| 2011 | $1.92B | $1.17M | 42.89% | 6.14% | 0.06% |
| 2012 | $2.12B | $68.44M | 43.67% | 9.49% | 3.24% |
| 2013 | $2.17B | $167.92M | 43.39% | 11.95% | 7.75% |
| 2014 | $2.24B | $158.04M | 43.40% | 10.30% | 7.06% |
| 2015 | $2.10B | $212.45M | 44.19% | 12.68% | 10.09% |
| 2016 | $2.12B | $233.68M | 45.96% | 14.45% | 11.05% |
| 2017 | $2.26B | $113.02M | 45.61% | 13.50% | 5.01% |
| 2018 | $2.78B | $238.79M | 45.04% | 13.35% | 8.60% |
| 2019 | $2.88B | $227.56M | 44.84% | 14.06% | 7.89% |
| 2020 | $3.78B | $728.10M | 52.62% | 26.96% | 19.25% |
| 2021 | $3.83B | $943.16M | 59.62% | 35.01% | 24.64% |
| 2022 | $3.31B | $569.18M | 53.16% | 23.59% | 17.19% |
| 2023 | $2.75B | $-118.38M | 48.07% | 14.52% | -4.30% |
| 2024 | $2.76B | $295.83M | 48.01% | 14.90% | 10.74% |
| 2025 | $2.86B | $241.68M | 53.08% | 12.49% | 8.46% |